Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell killing by phorbol ester--differentiated human leukemia cells

J B Weinberg

    Science (New York, N.Y.)
    |August 7, 1981
    PubMed
    Summary

    The tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) differentiates human leukemia (HL60) cells into non-dividing, cytotoxic macrophage-like cells. This TPA-induced differentiation shows potential for experimental leukemia treatment by targeting tumor cells.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Blood in the joint: effects of hemarthrosis on meniscus health and repair techniques.

    Osteoarthritis and cartilage·2020
    Same author

    Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL.

    Blood cancer journal·2016
    Same author

    Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

    Leukemia·2012
    Same author

    Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration.

    Arthritis research & therapy·2011
    Same author

    Rhizobium radiobacter bacteremia in a neonate.

    Infection·2011
    Same author

    Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.

    Leukemia·2011

    Area of Science:

    • Cell Biology
    • Cancer Research
    • Pharmacology

    Background:

    • Human leukemia cell line HL60 is a model for studying leukemia progression.
    • Tumor promoters can induce cellular differentiation.
    • Differentiation into non-dividing cells can halt cancer growth.

    Purpose of the Study:

    • To investigate the effect of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) on HL60 cell differentiation.
    • To determine if TPA-induced differentiated cells possess cytotoxic properties against tumor cells.
    • To explore the potential therapeutic application of TPA-induced differentiation in leukemia treatment.

    Main Methods:

    • Treatment of HL60 cells with 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
    • Assessment of cellular differentiation into macrophage-like cells.
    • In vitro cytotoxicity assays against HL60 tumor cells.

    Main Results:

    • TPA induced differentiation of HL60 cells into nondividing macrophage-like cells.
    • These differentiated HL60 cells exhibited significant cytotoxicity towards untreated HL60 tumor cells in vitro.
    • The differentiated cells were effective against their parent, untreated HL60 counterparts.

    Conclusions:

    • 12-O-tetradecanoyl-phorbol-13-acetate (TPA) effectively differentiates leukemia cells into antitumor effector cells.
    • TPA-induced differentiation results in cytotoxic, nondividing cells with potential anti-leukemia activity.
    • Agents inducing such differentiation may be valuable in experimental leukemia therapy.

    Related Experiment Videos